Cliff Asness's CDTX Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 3,758 shares of Cidara Therapeutics, Inc. (CDTX) worth $359,866, representing 0.00% of the portfolio. First purchased in 2025-Q3, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Cliff Asness has initiated a new position in CDTX, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Cidara Therapeutics (CDTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Cidara Therapeutics (CDTX) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2025 | +3,758 | New Buy | 3,758 | $95.76 |
Cliff Asness's Cidara Therapeutics Investment FAQs
Cliff Asness first purchased Cidara Therapeutics, Inc. (CDTX) in Q3 2025, acquiring 3,758 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Cidara Therapeutics, Inc. (CDTX) for 1 quarters since Q3 2025.
Cliff Asness's largest addition to Cidara Therapeutics, Inc. (CDTX) was in Q3 2025, adding 3,758 shares worth $359,866.
According to the latest 13F filing for Q3 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 3,758 shares of Cidara Therapeutics, Inc. (CDTX), valued at approximately $359,866.
As of the Q3 2025 filing, Cidara Therapeutics, Inc. (CDTX) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Cidara Therapeutics, Inc. (CDTX) was 3,758 shares, as reported at the end of Q3 2025.